Susan Orr
Direttore/Membro del Consiglio presso OPTHEA LIMITED
Patrimonio netto: - $ in data 30/04/2024
Profilo
Susan Orr is a professional with current positions as Non-Executive Director at Opthea Ltd., Director at Retina Global, and Chief Medical Officer at Claris Biotherapeutics, Inc. She previously worked as Chief Executive Officer at Notal Vision Ltd.
from 2016 to 2019.
Orr received her undergraduate and doctorate degrees from The University of Waterloo.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OPTHEA LIMITED
-.--% | 28/09/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Susan Orr
| Società | Posizione | Inizio |
|---|---|---|
| OPTHEA LIMITED | Direttore/Membro del Consiglio | 21/04/2022 |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Direttore operativo | - |
| Retina Global | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Susan Orr
| Società | Posizione | Fine |
|---|---|---|
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Amministratore Delegato | 23/10/2019 |
Formazione di Susan Orr
| The University of Waterloo | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Health Technology |
| Retina Global |
- Borsa valori
- Insiders
- Susan Orr
